NCT01964170View on ClinicalTrials.gov

A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

August 13, 2013

Primary Completion Date

June 5, 2015

Study Completion Date

August 8, 2016

Conditions
Prostate Cancer
Interventions
DRUG

degarelix

subcutaneous

DRUG

Goserelin

subcutaneous

Trial Locations (8)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01964170 - A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter